Login / Signup

Protocol for the melatools skin self-monitoring trial: a phase II randomised controlled trial of an intervention for primary care patients at higher risk of melanoma.

Katie MillsJon David EmeryRebecca LantaffMichael RadfordMerel PannebakkerPer HallNigel BurrowsKate WilliamsCatherine L SaundersPeter MurchieFiona Mary Walter
Published in: BMJ open (2017)
ISCTRN16061621.
Keyphrases
  • phase ii
  • randomized controlled trial
  • study protocol
  • primary care
  • open label
  • clinical trial
  • placebo controlled
  • phase iii
  • soft tissue
  • double blind
  • wound healing
  • skin cancer
  • general practice
  • basal cell carcinoma